Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2022-06-10 00:00:00 ET · period of report 2022-06-08 · accession 0001062993-22-014695 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-06-10 | 2022-06-08 | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -498.3K | 10.11M | -5% | $0 |
| 2022-06-10 | 2022-06-08 | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +27.5K | 295.2K | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-08 | J | A | 1,684 | $0.00 | 17,063 | I | — | — | (F5) Reclassified shares previously reported as direct to indirect to reflect these shares are held by a trust for the benefit of family members of the Reporting Person. |
| 2 | Common | Common Stock | 2022-06-08 | J | A | 27,489 | $0.00 | 295,234 | D See footnote | — | — | (F5) Reclassified shares previously reported as direct to indirect to reflect these shares are held by a trust for the benefit of family members of the Reporting Person. |
| 3 | Common | Common Stock | 2022-06-08 | J | D | 217,781 | $0.00 | 7,803,818 | I See footnote | — | — | (F2) The shares are held by ARCH Venture Fund IX, L.P. ("ARCH IX"). The Reporting Person is a managing director of ARCH Venture Partners IX, LLC, the sole general partner of ARCH Venture Partners IX, L.P., which is the sole general partner of ARCH IX, and shares voting and investment control with respect to shares held by ARCH IX. The Reporting Person may be deemed to beneficially own the shares held by ARCH IX, and the Reporting Person disclaims ownership of such shares, except to the extent of his pecuniary interest therein. |
| 4 | Common | Common Stock | 2022-06-08 | J | D | 282,219 | $0.00 | 10,112,845 | I See footnote | — | — | (F3) The shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). The Reporting Person is a managing director of ARCH Venture Partners IX, LLC, the sole general partner of ARCH Venture Partners IX Overage, L.P. ("Overage GPLP"), which is the sole general partner of ARCH Overage, and shares voting and investment control with respect to shares held by ARCH Overage. The Reporting Person disclaims ownership of such shares, except to the extent of his pecuniary interest therein. |